Targeted nanomedicine for reprogramming the tumor innate immune system: From bench to bedside
Article in European Journal of Pharmaceutics and Biopharmaceutics (September 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Recent Advances in Immune-Based Therapies for Acute Myeloid Leukemia.
Article in Blood Cancer Discovery (June 2024)
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells
Article in Frontiers in Immunology (May 2024)